Egypt Drug Authority: BE study conduct [Design Issues]

posted by Debbie – India, 2014-12-23 08:13 (4199 d 00:36 ago) – Posting: # 14148
Views: 5,170

Dear Sir,

As a CRO professional, we have received the studies for Egypt market. For that we would like to know about the conduct of Bioequivalence study.

Whether is it mandatory to conduct the bio-equivalence study in Egyptian population to meet the requirements of EDA (Egypt Drug Authority) or EDA (Egypt Drug Authority) will accept the bio-equivalence study conducted in compliance to the requirements of EDA (Egypt Drug Authority) in any other country population (Other than Egypt).

In listed EDA guidelines on the Bioequivalence study are not detailed about this.

Please respond the mail and advise me to take necessary steps for the conduct of the BE study.

Thanks & Regards,
Santhosh Kumar B


Edit: Category changed and subject line changed. [Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,572 registered users;
148 visitors (0 registered, 148 guests [including 38 identified bots]).
Forum time: 09:49 CEST (Europe/Vienna)

Scientists cannot simply hang their subjectivities
up on a hook outside the laboratory door.    Ruth Bleier

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5